2022-500905-42-00CompletedPhase 1
Phase 1b study investigating the association of NP137 with mFOLFIRINOX in locally advanced pancreatic ductal adenocarcinoma LAP NET 1
Source: EU CTIS (euclinicaltrials.eu) · Last updated 8 Apr 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 52 (actual)
- First submitted
- 18 Aug 2022
- Start date
- 24 Mar 2023
- Lead sponsor
- University Hospital Grenoble
- Diseases
- Pancreatic cancer
- EU CT number
- 2022-500905-42-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 52
- 10 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (10)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Assistance Publique Hopitaux De Paris | Bobigny | France | Completed |
| Centre Hospitalier Universitaire Grenoble Alpes | Grenoble Cedex 9 | France | Completed |
| CHU Lille | Lille Cedex | France | Completed |
| Centre Leon Berard | Lyon | France | Completed |
| Hôpital Privé Jean Mermoz | Lyon | France | Completed |
| Centre Hospitalier Universitaire de Bordeaux | Pessac | France | Completed |
| Centre Hospitalier Universitaire de Poitiers | Poitiers | France | Completed |
| Centre Hospitalier Universitaire De Reims | Reims Cedex | France | Completed |
| Centre Hospitalier Universitaire De Rennes | Rennes Cedex 9 | France | Completed |
| Centre Hospitalier Universitaire de Saint Etienne | Saint-Priest-en-Jarez | France | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.